首页 正文

Advances in methotrexate nano-formulations to enhance therapeutic efficacy against drug-resistant breast cancer

{{output}}
Methotrexate (MTX), a widely used chemotherapeutic agent and folate antagonist, is commonly employed in the treatment of various cancers and immune-mediated inflammatory diseases. However, conventional MTX therapy is associated with several limitations, includ... ...